KDNY

Chinook Therapeutics, Inc.

Healthcare

Set alert

Price alert · KDNY

All alert types
40.39 0.00 0.00%
As of Aug 10, 2023
40.30 Day range 40.51

52-week range unavailable

Open
40.31
Prev close
40.39
Mkt cap
2.63B
Vol
3.28M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
40.30
High
40.51
Forward P/E
-11.37
Beta
0.68
Short ratio
1.24
Inst. own
96.29%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2023
50-d avg
29.15
200-d avg
24.27
1y target
39.30

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for KDNY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

9.74 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -9.1×
FY 2015: -156333×FY 2016: -40714×FY 2017: -28846×FY 2018: -11000×FY 2019: -5.3×FY 2020: -2.6×FY 2021: -7.3×FY 2022: -9.1×
FY 2015 5y median -7.3× FY 2022
P/S 275×
FY 2015: 86192×FY 2016: 73330×FY 2017: 158582×FY 2018: 68955×FY 2019: 14.4×FY 2020: 253×FY 2021: 14.4×FY 2022: 275×
FY 2015 5y median 253× FY 2022
P/B 3.8×
FY 2015: 24043×FY 2016: 16356×FY 2017: 11512×FY 2018: 7688×FY 2019: -6.0×FY 2020: 0.6×FY 2021: 1.6×FY 2022: 3.8×
FY 2015 5y median 1.6× FY 2022
P/FCF -14.2×
FY 2015: 41210×FY 2016: -33797×FY 2017: -29080×FY 2018: -14627×FY 2019: -17.3×FY 2020: -3.7×FY 2021: -7.1×FY 2022: -14.2×
FY 2015 5y median -14.2× FY 2022
EV/EBITDA -9.6×
FY 2015: -165132×FY 2016: -51715×FY 2017: -25679×FY 2018: -10262×FY 2019: -16.7×FY 2020: -0.8×FY 2021: -6.4×FY 2022: -9.6×
FY 2015 5y median -9.6× FY 2022
EV/Sales 263×
FY 2015: 86190×FY 2016: 73329×FY 2017: 158573×FY 2018: 68947×FY 2019: 13.9×FY 2020: 76.0×FY 2021: 11.7×FY 2022: 263×
FY 2015 5y median 76.0× FY 2022
FCF Yield -7.1%
FY 2015: 0.0%FY 2016: -0.0%FY 2017: -0.0%FY 2018: -0.0%FY 2019: -5.8%FY 2020: -27.1%FY 2021: -14.1%FY 2022: -7.1%
FY 2015 5y median -7.1% FY 2022

Profitability

Gross Margin 71.9%
FY 2015: 99.9%FY 2016: 98.9%FY 2017: 96.8%FY 2018: 96.1%FY 2019: 96.8%FY 2020: 49.0%FY 2021: 96.7%FY 2022: 71.9%
FY 2015 5y median 96.1% FY 2022
Operating Margin -3020.3%
FY 2015: -18.6%FY 2016: -141.8%FY 2017: -617.5%FY 2018: -671.8%FY 2019: -115.7%FY 2020: -6798.9%FY 2021: -191.8%FY 2022: -3020.3%
FY 2015 5y median -671.8% FY 2022
Net Margin -3012.6%
FY 2015: -53.7%FY 2016: -179.8%FY 2017: -532.9%FY 2018: -632.0%FY 2019: -271.5%FY 2020: -9869.6%FY 2021: -196.2%FY 2022: -3012.6%
FY 2015 5y median -632.0% FY 2022
ROE -41.8%
FY 2015: -15.0%FY 2016: -40.1%FY 2017: -38.7%FY 2018: -70.5%FY 2019: 113.9%FY 2020: -24.4%FY 2021: -22.3%FY 2022: -41.8%
FY 2015 5y median -24.4% FY 2022
ROIC -35.0%
FY 2015: -3.0%FY 2016: -17.6%FY 2017: -23.5%FY 2018: -30.7%FY 2019: -147.5%FY 2020: -13.4%FY 2021: -18.8%FY 2022: -35.0%
FY 2015 5y median -30.7% FY 2022
ROA -32.2%
FY 2015: -8.1%FY 2016: -20.8%FY 2017: -20.6%FY 2018: -26.7%FY 2019: -298.0%FY 2020: -19.0%FY 2021: -18.0%FY 2022: -32.2%
FY 2015 5y median -26.7% FY 2022

Growth (YoY)

Revenue -88.1%
FY 2015: 0.0%FY 2016: -30.6%FY 2017: -66.0%FY 2018: -12.5%FY 2019: 14.4%FY 2020: -95.2%FY 2021: 6142.4%FY 2022: -88.1%
FY 2015 FY 2022
Operating Income -86.9%
FY 2015: 0.0%FY 2016: -429.8%FY 2017: -48.1%FY 2018: 4.8%FY 2019: 80.3%FY 2020: -181.6%FY 2021: -76.1%FY 2022: -86.9%
FY 2015 FY 2022
EPS (diluted) -29.3%
FY 2015: 0.0%FY 2016: -55.6%FY 2017: 7.1%FY 2018: 7.7%FY 2019: -92400.0%FY 2020: -458.6%FY 2021: 64.2%FY 2022: -29.3%
FY 2015 FY 2022
Free Cash Flow -13.9%
FY 2015: 0.0%FY 2016: -172.0%FY 2017: 14.5%FY 2018: 24.3%FY 2019: 79.8%FY 2020: -294.8%FY 2021: -84.7%FY 2022: -13.9%
FY 2015 FY 2022

Financial Health

Current Ratio 7.6×
FY 2015: 13.7×FY 2016: 11.6×FY 2017: 8.5×FY 2018: 9.3×FY 2019: 5.2×FY 2020: 11.1×FY 2021: 7.5×FY 2022: 7.6×
FY 2015 5y median 7.6× FY 2022
Quick Ratio 7.6×
FY 2015: 13.7×FY 2016: 11.6×FY 2017: 8.5×FY 2018: 9.3×FY 2019: 6.4×FY 2020: 11.1×FY 2021: 7.5×FY 2022: 7.6×
FY 2015 5y median 7.6× FY 2022
Debt / Equity 0.1×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×
FY 2015 5y median 0.1× FY 2022
Net Debt / EBITDA 0.5×
FY 2015: 3.9×FY 2016: 1.0×FY 2017: 1.5×FY 2018: 1.2×FY 2019: 0.6×FY 2020: 1.8×FY 2021: 1.5×FY 2022: 0.5×
FY 2015 5y median 1.2× FY 2022
Interest Coverage -25.8×
FY 2015: -27.5×FY 2016: -32.4×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -605×FY 2020: -3748×FY 2021: 0.0×FY 2022: -25.8×
FY 2015 5y median -25.8× FY 2022

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2015 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2015 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31